Inventor

ROMMELAERE JEAN

DE34 patents

⚠️ This page may combine multiple inventors who share the name “ROMMELAERE JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROMMELAERE JEAN

DEUTSCHES KREBSFORSCH

Use of parvovirus for brain tumor therapy

Cancer therapy with a parvovirus combined with an HDAC inhibitor

Parvovirus formulation for treating tumors

Adenovirus derived helper virus for enhancing recombinant parvovirus production

Method for large scale production and purification of parvovirus

Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles

Oncolytic virotherapy for the therapy of ewing&#39;S sarcoma

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

Parvovirus formulation for treating tumors

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

Modified parvovirus useful for gene silencing

Cancer therapy with a parvovirus combined with a BCL-2 inhibitor

Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor

Adeno-parvovirus chimera with enhanced oncolytical potential

Cancer therapy with a parvovirus combined with bevacizumab

Use of parvovirus for eliminating cancer stem cells (CSCs)

Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid

Modified parvovirus having enhanced anti-tumor efficacy

ROMMELAERE JEAN

Parvovirus cancer therapy and combination with chemotherapy

Oncolytic virotherapy for prevention of tumor recurrence

Use of parvovirus for eliminating cancer stem cells (CSCs)

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS

Optimized parvovirus H-1 production

Parovirus having a CpG-enriched genome useful for cancer therapy

UNIV HEIDELBERG RUPRECHT KARLS

Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer

KIPRIJANOVA IRINA

Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma

LEUCHS BARBARA

Antibody that binds to H-1 parvovirus

UNIV YALE

Parvovirus vectors and their use

DEUTSCHES KRABSFORSCHUNGZENTRU

Parvovirus NS1 variants

DAEFFLER LAURENT

Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis

RAYKOV ZAHARI

Parvovirus having a CPG-enriched genome useful for cancer therapy

NUEESCH JUERG

Polynucleotide encoding a fusion polypeptide suitable as cytotoxin

GIESE NATHALIA

Methods of treating cancer using chemovirotherapy

DEUTSCHES KREBS FORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS

Method for predicting the clinical response of oncolytic parvovirus H1 (H-1PV) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient&#39;s sample

NÜESCH JÜRG

Modified rodent parvovirus capable of propagating and spreading through human gliomas

Oncolytic virotherapy for the therapy of ewing'S sarcoma

Method for predicting the clinical response of oncolytic parvovirus H1 (H-1PV) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient's sample